SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotechnology Value Fund, L.P.
An SI Board Since January 1998
Posts SubjectMarks Bans
4974 145 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromPosted
4174about time! emphasis mine, from yesterday's BioCentury Extra (thanks, R.!).scaram(o)uche1/22/2005
4173Thanks for posting that. A much better place for this discussion???...... Subjscaram(o)uche1/22/2005
4172<i>brokers make clients buy shares to cover naked short positions.) </itom pope1/22/2005
4171MSN's "Crunch time on naked short selling is here", found at the MLD381/22/2005
4170WASHINGTON, Jan 21 (Reuters) - Biopharmaceutical firm Lexicon Genetics Inc. (LEXnigel bates1/22/2005
4169Tercica Files Registration Statement for Follow-On Offering Friday January 21, 7scaram(o)uche1/21/2005
4168Biotech Company ViaCell Debuts on Nasdaq Friday January 21, 4:56 pm ET Biotechscaram(o)uche1/21/2005
4167SAN DIEGO, Jan. 21 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdanigel bates1/21/2005
4166OT - Vivendi Inquiry Shines Light on 'Premarketing' Gauging Large InvesDoc Bones1/21/2005
4165Starting Up: Venture Funding Turns Positive By ANN GRIMES Staff Reporter of THDoc Bones1/21/2005
4164Bioenvision Announces Public Offering Of 7,000,000 Shrs Of Common Stk DOW JONESmopgcw1/21/2005
4163AlgoRx Pharma Sets IPO At 6.8M Shares, $10-$12 A Share DOW JONES NEWSWIRES Janumopgcw1/21/2005
4162Onyx Pharma Files $250M Mixed Securities Shelf DOW JONES NEWSWIRES January 20, mopgcw1/21/2005
4161ViaCell 7.5M Share IPO Priced At $7/Shr DOW JONES NEWSWIRES January 20, 2005 6:mopgcw1/21/2005
4160Amylin Pharma Secondary Offer Prices 8M Shrs At $22/Shr DOW JONES NEWSWIRES Janmopgcw1/21/2005
4159Ista Pharm Secondary Offer Prices 5.5M Shrs At $8.88/Shr DOW JONES NEWSWIRES Jamopgcw1/21/2005
4158Thanks for the pointer! 2004, second best funding year, all-time.scaram(o)uche1/20/2005
4157Signals looks at the past year in biotech financing, and peers ahead into the IPtuck1/20/2005
4156It's going to wild and wooly, going forward..... lotsa companies chasing ascaram(o)uche1/20/2005
4155It's going to wild and wooley, going forward..... lotsa companies chasing scaram(o)uche1/20/2005
4154Pfizer Nears a Deal To Acquire Angiosyn, Pad Eye-Drug Roster By ANN GRIMES and Doc Bones1/20/2005
4153<<Synta Pharmaceuticals>> Message 20962114michael_f_murphy1/19/2005
4152UPDATE 1-Synta Pharmaceuticals seeking $115 mln IPO Tue Jan 18, 2005 04:00 PM ETscaram(o)uche1/18/2005
4151Arena Pharmaceuticals Announces Public Offering of Common Stock January 13, 20sjemmeri1/13/2005
4150They sold an additional $25m. Do prospective bond holders get an inside look atkeokalani'nui1/12/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News